Brown Financial Advisors acquired a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 3,276 shares of the financial services provider’s stock, valued at approximately $644,000.
Other large investors have also recently made changes to their positions in the company. Salomon & Ludwin LLC acquired a new position in CME Group in the 1st quarter worth approximately $28,000. Y.D. More Investments Ltd acquired a new stake in shares of CME Group in the second quarter worth $36,000. McClarren Financial Advisors Inc. raised its holdings in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC lifted its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Finally, Rise Advisors LLC purchased a new stake in CME Group in the first quarter valued at $41,000. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Stock Down 0.8 %
CME opened at $223.57 on Thursday. The company has a market cap of $80.50 billion, a PE ratio of 25.43, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $225.95. The company has a 50-day moving average price of $211.20 and a 200 day moving average price of $207.59. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.06%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.
Insider Transactions at CME Group
In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have weighed in on CME. TD Cowen initiated coverage on CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Barclays upped their price objective on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Finally, Royal Bank of Canada assumed coverage on shares of CME Group in a report on Friday, September 27th. They issued a “sector perform” rating and a $235.00 price objective for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $212.54.
Get Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- 3 Small Caps With Big Return Potential
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Want to Profit on the Downtrend? Downtrends, Explained.
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.